Unresponsive Aplastic Anemia Patients May Benefit From Eltrombopag

Eltrombopag, a drug that was designed to stimulate production of platelets from the bone marrow and thereby improve blood clotting, can raise blood cell levels in some people with severe aplastic anemia who have failed all standard therapies. About one-third of aplastic anemia cases do not respond to standard therapy, a combination of immune-suppressing drugs...

Source: http://www.medicalnewstoday.com/releases/247469.php

Mika Hakkinen Sebastian Vettel Riccardo Patrese Alain Prost